1 Xeloda Market Overview 1.1 Product Overview and Scope of Xeloda 1.2 Xeloda Segment by Type 1.2.1 Global Xeloda Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 500 mg 1.2.3 150 mg 1.3 Xeloda Segment by Application 1.3.1 Xeloda Sales Comparison by Application: (2021-2027) 1.3.2 Breast Cancer 1.3.3 Colorectal cancer 1.3.4 Stomach Cancer 1.4 Global Xeloda Market Size Estimates and Forecasts 1.4.1 Global Xeloda Revenue 2016-2027 1.4.2 Global Xeloda Sales 2016-2027 1.4.3 Xeloda Market Size by Region: 2016 Versus 2021 Versus 2027 2 Xeloda Market Competition by Manufacturers 2.1 Global Xeloda Sales Market Share by Manufacturers (2016-2021) 2.2 Global Xeloda Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Xeloda Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Xeloda Manufacturing Sites, Area Served, Product Type 2.5 Xeloda Market Competitive Situation and Trends 2.5.1 Xeloda Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Xeloda Players Market Share by Revenue 2.5.3 Global Xeloda Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Xeloda Retrospective Market Scenario by Region 3.1 Global Xeloda Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Xeloda Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Xeloda Market Facts & Figures by Country 3.3.1 North America Xeloda Sales by Country 3.3.2 North America Xeloda Revenue by Country 3.3.3 United States 3.3.4 Canada 3.3.3 Mexico 3.4 Europe Xeloda Market Facts & Figures by Country 3.4.1 Europe Xeloda Sales by Country 3.4.2 Europe Xeloda Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 UK 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Xeloda Market Facts & Figures by Region 3.5.1 Asia Pacific Xeloda Sales by Region 3.5.2 Asia Pacific Xeloda Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Indonesia 3.5.9 Thailand 3.5.10 Malaysia 3.5.11 Philippines 3.5.12 Vietnam 3.6 Latin America Xeloda Market Facts & Figures by Country 3.6.1 Latin America Xeloda Sales by Country 3.6.2 Latin America Xeloda Revenue by Country 3.6.3 Brazil 3.7 Middle East and Africa Xeloda Market Facts & Figures by Country 3.7.1 Middle East and Africa Xeloda Sales by Country 3.7.2 Middle East and Africa Xeloda Revenue by Country 3.7.3 Turkey 3.7.4 GCC Countries 3.7.5 Egypt 3.7.6 South Africa 4 Global Xeloda Historic Market Analysis by Type 4.1 Global Xeloda Sales Market Share by Type (2016-2021) 4.2 Global Xeloda Revenue Market Share by Type (2016-2021) 4.3 Global Xeloda Price by Type (2016-2021) 5 Global Xeloda Historic Market Analysis by Application 5.1 Global Xeloda Sales Market Share by Application (2016-2021) 5.2 Global Xeloda Revenue Market Share by Application (2016-2021) 5.3 Global Xeloda Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Roche 6.1.1 Roche Corporation Information 6.1.2 Roche Description and Business Overview 6.1.3 Roche Xeloda Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Roche Product Portfolio 6.1.5 Roche Recent Developments/Updates 6.2 Teva 6.2.1 Teva Corporation Information 6.2.2 Teva Description and Business Overview 6.2.3 Teva Xeloda Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Teva Product Portfolio 6.2.5 Teva Recent Developments/Updates 6.3 Mylan 6.3.1 Mylan Corporation Information 6.3.2 Mylan Description and Business Overview 6.3.3 Mylan Xeloda Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Mylan Product Portfolio 6.3.5 Mylan Recent Developments/Updates 6.4 Hikma 6.4.1 Hikma Corporation Information 6.4.2 Hikma Description and Business Overview 6.4.3 Hikma Xeloda Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Hikma Product Portfolio 6.4.5 Hikma Recent Developments/Updates 6.5 Hengrui Medicine 6.5.1 Hengrui Medicine Corporation Information 6.5.2 Hengrui Medicine Description and Business Overview 6.5.3 Hengrui Medicine Xeloda Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Hengrui Medicine Product Portfolio 6.5.5 Hengrui Medicine Recent Developments/Updates 6.6 Cipla 6.6.1 Cipla Corporation Information 6.6.2 Cipla Description and Business Overview 6.6.3 Cipla Xeloda Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Cipla Product Portfolio 6.6.5 Cipla Recent Developments/Updates 6.7 Reliance Group 6.6.1 Reliance Group Corporation Information 6.6.2 Reliance Group Description and Business Overview 6.6.3 Reliance Group Xeloda Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Reliance Group Product Portfolio 6.7.5 Reliance Group Recent Developments/Updates 6.8 Hetero 6.8.1 Hetero Corporation Information 6.8.2 Hetero Description and Business Overview 6.8.3 Hetero Xeloda Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Hetero Product Portfolio 6.8.5 Hetero Recent Developments/Updates 7 Xeloda Manufacturing Cost Analysis 7.1 Xeloda Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Xeloda 7.4 Xeloda Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Xeloda Distributors List 8.3 Xeloda Customers 9 Xeloda Market Dynamics 9.1 Xeloda Industry Trends 9.2 Xeloda Growth Drivers 9.3 Xeloda Market Challenges 9.4 Xeloda Market Restraints 10 Global Market Forecast 10.1 Xeloda Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Xeloda by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Xeloda by Type (2022-2027) 10.2 Xeloda Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Xeloda by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Xeloda by Application (2022-2027) 10.3 Xeloda Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Xeloda by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Xeloda by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Xeloda Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Xeloda Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Xeloda Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Xeloda Covered in This Study Table 5. Global Xeloda Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Xeloda Sales Share by Manufacturers (2016-2021) Table 7. Global Xeloda Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Xeloda Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Xeloda Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Xeloda Manufacturing Sites and Area Served Table 11. Manufacturers Xeloda Product Type Table 12. Global Xeloda Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Xeloda by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xeloda as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Xeloda Sales by Region (2016-2021) & (K MT) Table 16. Global Xeloda Sales Market Share by Region (2016-2021) Table 17. Global Xeloda Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Xeloda Sales by Country (2016-2021) & (K MT) Table 19. North America Xeloda Sales Market Share by Country (2016-2021) Table 20. North America Xeloda Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Xeloda Revenue Market Share by Country (2016-2021) Table 22. Europe Xeloda Sales by Country (2016-2021) & (K MT) Table 23. Europe Xeloda Sales Market Share by Country (2016-2021) Table 24. Europe Xeloda Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Xeloda Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Xeloda Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Xeloda Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Xeloda Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Xeloda Revenue Market Share by Region (2016-2021) Table 30. Latin America Xeloda Sales by Country (2016-2021) & (K MT) Table 31. Latin America Xeloda Sales Market Share by Country (2016-2021) Table 32. Latin America Xeloda Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Xeloda Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Xeloda Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Xeloda Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Xeloda Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Xeloda Revenue Market Share by Country (2016-2021) Table 38. Global Xeloda Sales (K MT) by Type (2016-2021) Table 39. Global Xeloda Sales Market Share by Type (2016-2021) Table 40. Global Xeloda Revenue (Million US$) by Type (2016-2021) Table 41. Global Xeloda Revenue Share by Type (2016-2021) Table 42. Global Xeloda Price (USD/MT) by Type (2016-2021) Table 43. Global Xeloda Sales (K MT) by Application (2016-2021) Table 44. Global Xeloda Sales Market Share by Application (2016-2021) Table 45. Global Xeloda Revenue (Million US$) by Application (2016-2021) Table 46. Global Xeloda Revenue Share by Application (2016-2021) Table 47. Global Xeloda Price (USD/MT) by Application (2016-2021) Table 48. Roche Corporation Information Table 49. Roche Description and Business Overview Table 50. Roche Xeloda Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Roche Xeloda Product Table 52. Roche Recent Developments/Updates Table 53. Teva Corporation Information Table 54. Teva Description and Business Overview Table 55. Teva Xeloda Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Teva Xeloda Product Table 57. Teva Recent Developments/Updates Table 58. Mylan Corporation Information Table 59. Mylan Description and Business Overview Table 60. Mylan Xeloda Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Mylan Xeloda Product Table 62. Mylan Recent Developments/Updates Table 63. Hikma Corporation Information Table 64. Hikma Description and Business Overview Table 65. Hikma Xeloda Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Hikma Xeloda Product Table 67. Hikma Recent Developments/Updates Table 68. Hengrui Medicine Corporation Information Table 69. Hengrui Medicine Description and Business Overview Table 70. Hengrui Medicine Xeloda Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Hengrui Medicine Xeloda Product Table 72. Hengrui Medicine Recent Developments/Updates Table 73. Cipla Corporation Information Table 74. Cipla Description and Business Overview Table 75. Cipla Xeloda Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Cipla Xeloda Product Table 77. Cipla Recent Developments/Updates Table 78. Reliance Group Corporation Information Table 79. Reliance Group Description and Business Overview Table 80. Reliance Group Xeloda Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. Reliance Group Xeloda Product Table 82. Reliance Group Recent Developments/Updates Table 83. Hetero Corporation Information Table 84. Hetero Description and Business Overview Table 85. Hetero Xeloda Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. Hetero Xeloda Product Table 87. Hetero Recent Developments/Updates Table 88. Production Base and Market Concentration Rate of Raw Material Table 89. Key Suppliers of Raw Materials Table 90. Xeloda Distributors List Table 91. Xeloda Customers List Table 92. Xeloda Market Trends Table 93. Xeloda Growth Drivers Table 94. Xeloda Market Restraints Table 95. Global Xeloda Sales Forecast by Type (2022-2027) & (K MT) Table 96. Global Xeloda Sales Market Share Forecast by Type (2022-2027) Table 97. Global Xeloda Revenue Forecast by Type (2022-2027) & (US$ Million) Table 98. Global Xeloda Revenue Market Share Forecast by Type (2022-2027) Table 99. Global Xeloda Sales Forecast by Application (2022-2027) & (K MT) Table 100. Global Xeloda Sales Market Share Forecast by Application (2022-2027) Table 101. Global Xeloda Revenue Forecast by Application (2022-2027) & (US$ Million) Table 102. Global Xeloda Revenue Market Share Forecast by Application (2022-2027) Table 103. Global Xeloda Sales Forecast by Region (2022-2027) & (K MT) Table 104. Global Xeloda Sales Market Share Forecast by Region (2022-2027) Table 105. Global Xeloda Revenue Forecast by Region (2022-2027) & (US$ Million) Table 106. Global Xeloda Revenue Market Share Forecast by Region (2022-2027) Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Xeloda Figure 2. Global Xeloda Market Share by Type in 2020 & 2027 Figure 3. 500 mg Product Picture Figure 4. 150 mg Product Picture Figure 5. Global Xeloda Market Share by Application in 2020 & 2027 Figure 6. Breast Cancer Figure 7. Colorectal cancer Figure 8. Stomach Cancer Figure 9. Global Xeloda Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Xeloda Market Size 2016-2027 (US$ Million) Figure 11. Global Xeloda Sales 2016-2027 (K MT) Figure 12. Global Xeloda Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Xeloda Sales Share by Manufacturers in 2020 Figure 14. Global Xeloda Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Xeloda Players: Market Share by Revenue in 2020 Figure 16. Xeloda Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Xeloda Sales Market Share by Region (2016-2021) Figure 18. Global Xeloda Sales Market Share by Region in 2020 Figure 19. Global Xeloda Revenue Market Share by Region (2016-2021) Figure 20. Global Xeloda Revenue Market Share by Region in 2020 Figure 21. United States Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Mexico Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. UK Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Brazil Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Turkey Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. GCC Countries Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Egypt Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. South Africa Xeloda Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Sales Market Share of Xeloda by Type (2016-2021) Figure 45. Sales Market Share of Xeloda by Application (2016-2021) Figure 46. Sales Market Share of Xeloda by Application in 2020 Figure 47. Revenue Share of Xeloda by Application (2016-2021) Figure 48. Revenue Share of Xeloda by Application in 2020 Figure 49. Manufacturing Cost Structure of Xeloda Figure 50. Manufacturing Process Analysis of Xeloda Figure 51. Xeloda Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Roche Teva Mylan Hikma Hengrui Medicine Cipla Reliance Group Hetero